| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 78,601 | 77,836 | 77,567 | 71,669 | | Cost of Revenue | 3,432 | 12,400 | 11,831 | 12,264 | | | Gross Profit | 65,432 | 65,436 | 65,736 | 59,405 | | | Operating Expenses | | Research Development | 13,695 | 12,606 | 12,846 | 13,476 | | Selling General and Administrative | 50,473 | 51,440 | 51,054 | 55,158 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 9,737 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,264 | 1,390 | 1,836 | (9,229) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 183 | 72 | 357 | (169) | | Earnings Before Interest And Taxes | 1,447 | 1,462 | 2,193 | (9,398) | | Interest Expense | 1,700 | 1,747 | 2,212 | 2,777 | | Income Before Tax | (253) | (285) | (19) | (12,175) | | Income Tax Expense | 1,672 | (3,620) | 1,068 | (3,323) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,925) | 3,335 | (1,087) | (8,852) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,925) | 3,335 | (1,087) | (8,852) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,925) | $3,335 | ($1,087) | ($8,852) |
|
0.26% Nasdaq 
0.04 (0.22%) 
Income Statement
